OLARATUMAB
UNII TT6HN20MVF

Substance Identification & Data

This profile provides standardized clinical and technical data for Olaratumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) TT6HN20MVF.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1024603-93-7 and the RxNorm Concept ID (RxCUI) 1855735. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

TT6HN20MVF

CAS Registry Number

1024603-93-7

RxNorm Concept ID

1855735

Detailed Substance Profile

Preferred Name

OLARATUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C79825

National Cancer Institute reference terminology for clinical and research data.

INN ID

9308

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

WW-104

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Olaratumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

OLARATUMAB

Common Names & Synonyms

IMMUNOGLOBULIN G1, ANTI-(HUMAN PLATELET-DERIVED GROWTH FACTOR RECEPTOR .ALPHA.) (HUMAN MONOCLONAL 3G3 .GAMMA.-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL 3G3 .KAPPA.-CHAIN, DIMER

OLARATUMAB [INN]

OLARATUMAB [JAN]

OLARATUMAB [MI]

OLARATUMAB [PURPLE BOOK CDER]

OLARATUMAB [USAN]

OLARATUMAB [WHO-DD]